Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025)
Autolus Therapeutics posted quarterly FCF Margin of 199.91% for Q4 2025, up 9898629.0% year-on-year from N/an in Q4 2024, and up 41.4% on a QoQ basis from 341.17% in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of FCF Margin data on file, last reported at 199.91% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 9898629.0% year-over-year to 199.91%; the trailing twelve-month figure through Dec 2025 stood at 377.69% (up 167646.0% YoY), and the FY2025 full-year result was 377.69%, up 167828.0% from the prior year.
- FCF Margin for Q4 2025 stood at 199.91%, up from 341.17% in the prior quarter.
- Across five years, FCF Margin topped out at 2126.75% in Q4 2021 and bottomed at 99186.21% in Q4 2024.
- The 5-year median for FCF Margin is 2329.13% (2021), against an average of 12600.49%.
- The widest annual swing landed in 2022, when FCF Margin tumbled 746212 bps; it then soared 9898629 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 2126.75% in 2021, then sank by 1070 bps to 20637.95% in 2022, then soared by 43 bps to 11683.5% in 2023, then tumbled by 749 bps to 99186.21% in 2024, then jumped by 100 bps to 199.91% in 2025.
- The last three FCF Margin figures came in at 199.91% (Q4 2025), 341.17% (Q3 2025), and 382.63% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 43.35% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 23.53% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.17% |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -199.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -199.91% |
| Sep 30, 2025 | -341.17% |
| Jun 30, 2025 | -382.63% |
| Mar 31, 2025 | -933.07% |
| Dec 31, 2024 | -99,186.21% |
| Mar 31, 2024 | -406.62% |
| Sep 30, 2023 | -11,683.50% |
| Mar 31, 2023 | -3,568.96% |
| Mar 31, 2022 | -20,637.95% |
| Dec 31, 2021 | 2,126.75% |
| Sep 30, 2021 | -13,088.14% |
| Jun 30, 2021 | -2,329.13% |
| Mar 31, 2021 | -13,175.84% |
| Dec 31, 2020 | -12,777.23% |
| Sep 30, 2020 | -7,993.84% |
| Jun 30, 2020 | -8,331.06% |
| Mar 31, 2020 | -6,330.18% |
| Dec 31, 2017 | -3,808.23% |